Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9771359
SERIAL NO

15603280

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MEDIFRON DBT INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bahrenberg, Gregor Monschau-Konzen, DE 59 502
Christoph, Thomas Aachen, DE 80 536
Damann, Nils Hürth, DE 13 63
Frank-Foltyn, Robert Beiseförth, DE 2 0
Frormann, Sven Aachen, DE 12 155
Habermann, Christopher Aachen, DE 1 0
Lee, Jeewoo Seoul, KR 27 250
Lesch, Bernhard Aachen, DE 15 68
Saunders, Derek Aachen, DE 22 265
Schiene, Klaus Jüchen, DE 112 545
Stockhausen, Hannelore Hürtgenwald, DE 5 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00